07:00 , Jun 28, 2010 |  BC Week In Review  |  Company News

Biomerica deal

Biomerica purchased from an undisclosed company the technology and manufacturing rights to an ELISA-based thiopurine S-methyltransferase (TPMT) test. The test detects patients who lack the TPMT enzyme and cannot remove thiopurines from the body, making...
07:00 , May 4, 2009 |  BC Week In Review  |  Company News

Biomerica deal

Biomerica purchased the assets, technology and rights to three diagnostics for Celiac disease from an undisclosed European company for an undisclosed sum. The assets include a test marketed in Europe to detect antibodies to tissue...
08:00 , Feb 14, 2005 |  BC Week In Review  |  Company News

Biomerica sales and marketing update

The company launched a blood test that measures the levels of C-peptide in blood to differentiate between Type I and Type II diabetes. Biomerica Inc. (BMRA), Newport Beach, Calif.   Business: Diagnostic  ...
08:00 , Feb 2, 2004 |  BC Week In Review  |  Clinical News

Diagnostics for testing patient samples regulatory update

Europe granted CE Mark approval for all BMRA products, including its Isletest diabetes test, Allequant allergy food tests, GAP h. pylori tests, and EZ Detect/EZ-PSA/EZ-HP in-office and in-home tests. Biomerica Inc. (BMRA), Newport Beach, Calif....
07:00 , Jul 16, 2001 |  BC Week In Review  |  Company News

Biomerica, ICN sales and marketing update

ICN's ICN Diagnostics division will distribute BMRA's clinical laboratory and point-of-care diagnostics, including BMRA's diabetes, gastrointestinal and thyroid tests. Biomerica Inc. (BMRA), Newport Beach, Calif.   ICN Pharmaceuticals Inc. (ICN), Costa Mesa, Calif.   Business:...
07:00 , Aug 21, 2000 |  BC Week In Review  |  Company News

Biomerica sales and marketing update

BMRA launched its Pepgen ELISA test to detect and monitor the presence of peptic ulcers and gastric carcinoma by quantifying amounts of Pepsinogen-1 present in human serum. Biomerica Inc. (BMRA), Newport Beach, Calif.   Business:...
07:00 , Apr 3, 2000 |  BC Week In Review  |  Company News

Biomerica sales and marketing update

BMRA launched outside the U.S. its GliaQuant-IgG test to detect and monitor the presence of gliadin , a protein in the gluten of wheat, rye, barley and oats that causes Celiac disease. Biomerica Inc. (BMRA),...
07:00 , Apr 3, 2000 |  BC Week In Review  |  Company News

Biomerica, Sentinel CH. s.r.l. sales and marketing update

Sentinel will exclusively market and distribute for two years BMRA's Allerquant Med90 food allergy test in Italy. Biomerica Inc. (BMRA), Newport Beach, Calif.   Sentinel CH. s.r.l., Milan, Italy   Business: Diagnostics/Imaging  ...
08:00 , Nov 15, 1999 |  BC Week In Review  |  Company News

Biomerica management update

Biomerica Inc. (BMRA), Newport Beach, Calif.   Business: Diagnostics/Imaging   Hired: Michael Lombardi as EVP of marketing and sales, formerly SVP of Beech Street Corp.  ...
07:00 , Oct 4, 1999 |  BC Week In Review  |  Company News

Biomerica management update

Biomerica Inc. (BMRA), Newport Beach, Calif.   Business: Diagnostics/Imaging, Supply/Service   Hired: Steven Goto as chief technology officer, formerly director of information technology for autobytel.com Inc.  ...